News

Public · Published

Astrana Health (ASTH) reports Q3: everything you need to know ahead of earnings

Astrana Health is scheduled to report results Thursday afternoon. Last quarter, revenue was $972.5 million, up 48.5% year over year but below analysts' expectations. Its full-year revenue outlook was slightly below analyst expectations, while its full-year EBITDA outlook, a measure of operating earnings, met them.

Published:

Updated:

What happened

Astrana Health is scheduled to report results Thursday afternoon. Last quarter, revenue was $972.5 million, up 48.5% year over year but below analysts’ expectations. Its full-year revenue outlook was slightly below analyst expectations, while its full-year EBITDA outlook, a measure of operating earnings, met them.

Confirmed

Global impact / market context

Investors will compare the new results and outlook with expectations for 6.8% year-over-year revenue growth, much slower than the 99.7% increase a year earlier. A shortfall could raise concerns about growth and put pressure on the company’s shares; meeting expectations could ease those concerns.

Analyst inference

Analysts have generally kept their estimates unchanged over the past 30 days, suggesting they expect the business to stay on course. However, Astrana has missed revenue estimates multiple times in the past two years, making actual revenue and forward guidance important tests for investor confidence.

Analyst inference

What to watch

  1. Check reported revenue against the market’s expected 6.8% year-over-year growth and compare the pace with last year’s 99.7% increase. Confirmed
  2. Review full-year revenue guidance for any change from the prior outlook, which slightly missed analysts’ expectations, and see whether EBITDA guidance still meets them. Analyst inference
  3. Assess whether results explain the repeated revenue shortfalls; sustained misses could weaken confidence in growth and make investors less willing to hold the shares. Analyst inference

Evidence